$ACT Headlines Actavis continues pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board

Jan 28, 2014 at 11:56 AM

$ACT Headlines

Actavis continues pharmaceuticals dominance 11:33 a.m. Jan. 16, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
BlackBerry gains on Facebook talk; Apple red 3:00 p.m. Oct. 29, 2013 - Sue Chang
FDA recommends new limits on pain drugs 10:25 p.m. Oct. 24, 2013 - Thomas M. Burton
Large investors refuse to sell this market 11:05 a.m. Oct. 1, 2013 - The Trading Deck
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey
James Dinan's top stock picks 9:11 a.m. Aug. 21, 2013 - Insider Monkey
Major U.S. benchmarks take technically shaky turn 11:18 a.m. Aug. 15, 2013 - Michael Ashbaugh
Dow holds major support, Nasdaq presses new highs 9:39 a.m. July 29, 2013 - Michael Ashbaugh
Perrigo to buy biotech Elan in $8.6 billion deal 3:51 a.m. July 29, 2013 - Jonathan D. Rockoff
Actavis, Warner shares climb as investors anticipate pending merger 2:07 p.m. July 26, 2013 - Russ Britt
Actavis loss widens on impairment charge 6:58 a.m. July 25, 2013 - MarketWatch.com
Charting a slow-motion rally to record territory 11:06 a.m. July 23, 2013 - Michael Ashbaugh
Charting a slow-motion rally to record territory 10:50 a.m. July 23, 2013 - Michael Ashbaugh
Hedge fund conference picks: winners and losers 6:17 p.m. July 16, 2013 - William L. Watts
Supreme Court satisfies few with ruling on generic drug settlements 4:30 p.m. June 18, 2013 - Russ Britt
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh

Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog 6:50 p.m. Jan. 27, 2014 - Zacks.com
Teva Falls on Negative CHMP Opinion - Analyst Blog 5:20 p.m. Jan. 27, 2014 - Zacks.com
Will Pfizer (PFE) Miss This Earnings Season? - Analyst Blog 4:50 p.m. Jan. 27, 2014 - Zacks.com
Allergan Slips on Restasis Challenge - Analyst Blog 1:50 p.m. Jan. 23, 2014 - Zacks.com
Pharma Stocks Like Actavis Continue To Dominate At The Start Of 2014 6:40 a.m. Jan. 23, 2014 - Seeking Alpha
Teva to Acquire NuPathe - Analyst Blog 4:58 p.m. Jan. 22, 2014 - Zacks.com
Narrower-than-Expected Loss at Ironwood, Shares Up - Analyst Blog 3:31 p.m. Jan. 22, 2014 - Zacks.com
Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape 8:42 a.m. Jan. 22, 2014 - Zacks.com
More U.S. Companies Realize China Isn’t Worth the Trouble 4:27 a.m. Jan. 22, 2014 - InvestorPlace.com
Mallinckrodt Up on FDA Approval - Analyst Blog 12:10 p.m. Jan. 21, 2014 - Zacks.com
Will Cubist Pharma (CBST) Miss Earnings? - Analyst Blog 9:40 a.m. Jan. 21, 2014 - Zacks.com
Actavis Joins the Divestment Bandwagon - Analyst Blog 5:55 p.m. Jan. 20, 2014 - Zacks.com
Will Forest Labs (FRX) Beat Earnings Again? - Analyst Blog 11:10 a.m. Jan. 20, 2014 - Zacks.com
Actavis sells generic-pharma ops in seven European markets 2:57 a.m. Jan. 19, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Actavis Announces Agreement with Aurobindo Pharma to Divest Commercial Operations in Seven Western European Countries 3:33 p.m. Jan. 18, 2014 - benzinga.com
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily
Actavis Leads the Way 10:21 a.m. Jan. 17, 2014 - TheStreet.com
BioLineRx Progresses with BL-8040 - Analyst Blog 5:10 p.m. Jan. 16, 2014 - Zacks.com
Actavis to exit China, Bisaro says too much trouble for too little profit 11:03 a.m. Jan. 16, 2014 - Seeking Alpha

Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF
Pharma Industry Technical Data: Zoetis, Avanir Pharma, Actavis, and Salix Pharma 7:30 a.m. Jan. 16, 2014 - PR Newswire - PRF
Actavis Announces Preliminary Financial Performance for FY 2013 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units 7:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Actavis' Generic Version of Micardis® Receives FDA Approval 4:57 p.m. Jan. 8, 2014 - PR Newswire
Actavis to Host 2014 Investor Meeting January 31 in New York 4:25 p.m. Jan. 6, 2014 - PR Newswire
Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana 8:00 a.m. Jan. 6, 2014 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
Actavis Receives Complete Response Letter from FDA For Progestin-Only Patch 8:00 a.m. Dec. 24, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
Actavis to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:25 a.m. Dec. 20, 2013 - PR Newswire
Vensun Pharmaceuticals, Inc. Completes Series B Financing 9:35 a.m. Dec. 19, 2013 - BusinessWire
Zimmer Holdings Names Paul Bisaro to Board of Directors 5:00 p.m. Dec. 16, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation 8:00 a.m. Dec. 11, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

South Florida Donor Network Honors 52 Heroic Donors

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Maurices Strengthens Position with Key Refinancing Deal

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Job Market Shifts: Adaptation vs. Fairness Dilemma

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Aflac's $200M Milestone in Cancer Charity Support

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

LeoLabs and SciTec Partner for $93.7M Space Force Deal

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Facility Solutions Group Climbs to Top 18 Electrical Spot

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...